Medvacon
Medvacon
  • Home
  • About Us
  • Services
    • Quality/Compliance
    • Talent Acquisition
  • Clients
  • Jobs
  • Media
  • Contact Us
  • More
    • Home
    • About Us
    • Services
      • Quality/Compliance
      • Talent Acquisition
    • Clients
    • Jobs
    • Media
    • Contact Us
  • Sign In
  • Create Account

  • My Account
  • Signed in as:

  • filler@godaddy.com


  • My Account
  • Sign out

Signed in as:

filler@godaddy.com

  • Home
  • About Us
  • Services
    • Quality/Compliance
    • Talent Acquisition
  • Clients
  • Jobs
  • Media
  • Contact Us

Account


  • My Account
  • Sign out


  • Sign In
  • My Account

CAPA, Deviation, Complaint Investigation & Closeout

MEDVACON delivers rigorous and comprehensive CAPA, Deviation & Complaint Investigation and Closeout services that are designed to help reduce the overall cost of compliance for Life Sciences organizations. 

When manufacturing pharmaceutical products, unexpected events can occur, for instance during production, analysis, transport, storage or even during the qualification and/or calibration of equipment. In the pharmaceutical industry these events are called deviations or non-conformances. Deviations could have a negative effect on the quality of the pharmaceutical products and could even result in a recall of the products. Furthermore, these deviations could be an indication that the quality system is functioning sub-optimally.

For these reasons, it is of the utmost importance to investigate these deviations. In such an investigation the following aspects are essential:


  • root cause analysis, to determine why the deviation occurred.
  • impact assessment, to determine the (possible) consequences of the deviation
  • define corrective and preventive actions (CAPA), to be sure that correct actions were taken to immediately reduce the impact of the deviation, and to prevent the deviation from re-occurring.


The FDA Expects:


  • Quality Systems staff are effectively integrated into manufacturing and involved in non-conformance investigations.
  • The investigation, conclusion and follow-up must be documented
  • Any deviation from the written procedures recorded and justified.
  • Any unexplained discrepancy (including a percentage of theoretical yield exceeding the maximum or minimum percentages established in master production and control records) or the failure of a batch or any of its components to meet any of its specifications shall be thoroughly investigated, whether or not the batch has already been distributed. (211.192)​
  • The investigation shall extend to other batches of the same drug product and other drug products that may have been associated with the specific failure or discrepancy. A written record of the investigation shall be made and shall include the conclusions and follow up. (211.192)


We offer our clients an FDA Compliant, comprehensive CAPA - Deviation - Non-Conformance Investigation and Closeout solution.

Example Projects

Aseptic Combination Product Manufacturing Client

Aseptic Combination Product Manufacturing Client

Aseptic Combination Product Manufacturing Client

MEDVACON was engaged by an Aseptic Combination Product client to conduct investigations into deviations and non-conformance's in the aseptic manufacturing suites used to produce the combination product.  MEDVACON deployed a team of experts to conduct the investigations and assist this client in meeting stringent FDA commitment timelines.  In performing these activities MEDVACON was engaged by the client to resolve a highly technical issue with the combination product mechanical components and successfully identified the issue and implemented a change to the process. While the FDA commitment timelines were met the team remains in place to assist this client with ongoing investigations and closeouts.    

Contract Manufacturer - Pharmaceuticals

Aseptic Combination Product Manufacturing Client

Aseptic Combination Product Manufacturing Client

MEDVACON was engaged by a Contract Manufacturer to assist with investigation and close out of self-reported open deviations and CAPA's in several functional areas within the manufacturing site. MEDVACON deployed a team and assigned a lead to each functional area to drive the investigations and closeouts to completion.  The MEDVACON team leads worked closely with each other and client leadership and were able to identify common root causes that impacted various functional areas.  Corrective actions were put in place to prevent future occurrences.  The MEDVACON team members followed this approach: conducted root cause analysis, to determine why the deviation occurred; conducted an impact assessment, to determine the (possible) consequences of the deviation; defined corrective and preventive actions (CAPA), to be sure that correct actions were taken to immediately reduce the impact of the deviation, and to prevent the deviation from re-occurring. 

Top
  • Home
  • About Us
  • Quality/Compliance
  • Talent Acquisition
  • Clients
  • Media
  • Contact Us
  • Request a Quote

Medvacon

35 Sparta Ave, Sparta NJ, 07871 --- 12760 High Bluff Drive, #250, San Diego CA, 92130

1-833-633-8226

Copyright © 2023 Medvacon - All Rights Reserved.

Big News!

Click below to read how Medvacon can assist in Aseptic Operations and evaluations, Remediation!

View Now!

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept